Oramed Pharmaceuticals

-$0.45 (-2.01%) As of 4:00 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORMP and other ETFs, options, and stocks.

About ORMP

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides.

CEO
Nadav Kidron
Employees
12
Headquarters
New York, New York
Founded
2002

ORMP Key Statistics

Market Cap
713.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
474.50K
High Today
$22.68
Low Today
$21.85
Open Price
$22.35
Volume
167.11K
52 Week High
$24.25
52 Week Low
$2.40

ORMP Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Nov 24, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure